BCAS2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 8.88178419700125E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.41190400984692E-11 |
Normal-vs-Stage2 |
7.60410000000267E-05 |
Normal-vs-Stage3 |
1.62769797640294E-12 |
Normal-vs-Stage4 |
1.62447832963153E-12 |
Stage1-vs-Stage2 |
7.385400E-01 |
Stage1-vs-Stage3 |
1.896620E-03 |
Stage1-vs-Stage4 |
2.7760999999904E-06 |
Stage2-vs-Stage3 |
1.777580E-01 |
Stage2-vs-Stage4 |
3.606400E-02 |
Stage3-vs-Stage4 |
2.466000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.4432899320127E-15 |
Normal-vs-AfricanAmerican |
6.32780050580095E-10 |
Normal-vs-Asian |
3.161000E-04 |
Caucasian-vs-AfricanAmerican |
6.928800E-01 |
Caucasian-vs-Asian |
6.688400E-01 |
AfricanAmerican-vs-Asian |
7.779800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62481139653892E-12 |
Normal-vs-Female |
5.04218888863761E-12 |
Male-vs-Female |
1.246410E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.59989996198584E-09 |
Normal-vs-Age(41-60Yrs) |
4.18554080283684E-14 |
Normal-vs-Age(61-80Yrs) |
1.66333613549341E-12 |
Normal-vs-Age(81-100Yrs) |
1.240690E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.179400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.927830E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.773800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.284200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.504800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.034600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.495200E-03 |
Normal-vs-Grade 2 |
3.1607000017253E-08 |
Normal-vs-Grade 3 |
1.62447832963153E-12 |
Normal-vs-Grade 4 |
1.62447832963153E-12 |
Grade 1-vs-Grade 2 |
8.096600E-01 |
Grade 1-vs-Grade 3 |
3.584100E-02 |
Grade 1-vs-Grade 4 |
2.124100E-03 |
Grade 2-vs-Grade 3 |
3.52250000001941E-06 |
Grade 2-vs-Grade 4 |
3.08959999806291E-08 |
Grade 3-vs-Grade 4 |
3.267600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.7354000000358E-06 |
Normal-vs-ccB subtype |
1.62447832963153E-12 |
ccA subtype-vs-ccB subtype |
7.09809988563848E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.08801856413265E-14 |
Normal-vs-N1 |
3.33340022251605E-10 |
N0-vs-N1 |
5.372200E-02 |
|
|